Pancreatic Cancer Research

ResearcherGhent University HospitalNo recent work listed

Sylvie Rottey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-2060-3725; OpenAlex author ID A5043348199. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 1 paper, 1 trial

Papers 1

  1. Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP … Co-author DOI 10.1016/j.esmoop.2023.101584↗

Trials 1

  1. Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI Principal investigator NCT04954599↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nuria Kotecki · 1 shared paper, 1 shared trial, 2023 · strength 0.51
  2. Henk M.W. Verheul · 1 shared trial, 2023 · strength 0.36
  3. Irene Brana · 1 shared trial, 2023 · strength 0.36
  4. Loes Jansen · 1 shared trial, 2023 · strength 0.36
  5. Jordi Ahnert Rodon · 1 shared paper, 2023 · strength 0.15
  6. Nathan Bahary · 1 shared paper, 2023 · strength 0.15
  7. Ignacio Garrido‐Laguna · 1 shared paper, 2023 · strength 0.15
  8. Wells A. Messersmith · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.